Thomas Jefferson University

Gary Brown

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records and Publicatio - Thomas Jefferson University
Address833 Chestnut Street
Philadelphia PA 19023
Phone215-928-3300
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Brown MM, Brown GC, Smith MR. Educational Costs Expended and Career Incomes in Advanced Healthcare Professions. AANA J. 2024 Feb; 92(1):7-16. PMID: 38289682.
      Citations:    
    2. Brown GC, Brown MM, Monigle MC. Cost-Utility Analysis of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration. Ophthalmol Retina. 2024 05; 8(5):431-446. PMID: 37981235.
      Citations:    
    3. Brown GC, Brown MM, Gierhart D, Olk RJ. Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost-Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration. Ophthalmol Ther. 2023 Oct; 12(5):2583-2608. PMID: 37430077.
      Citations:    
    4. Brown GC, Brown MM, Sharma S. Preference-based comparison of quality of life associated with vision loss in Black and White ophthalmic populations in the US. Can J Ophthalmol. 2024 02; 59(1):24-30. PMID: 36427536.
      Citations:    
    5. Brown GC, Brown MM, Stein JD, Sharma S. Quality of life associated with no light perception vision. Can J Ophthalmol. 2023 08; 58(4):361-368. PMID: 35472297.
      Citations:    
    6. Brown GC, Murphy RP. Re: Le et?al.: Associations between age-related eye diseases and Charles Bonnet Syndrome in participants of the Age-Related Eye Disease Study 2: Report Number 26 (Ophthalmology. 2022;129:233-235). Ophthalmology. 2022 06; 129(6):e66-e67. PMID: 35379481.
      Citations:    
    7. Brown GC, Brown MM, Chaudhry I, Stein JD. Opportunities to Reduce Potential Bias in Ophthalmic Cost-Utility Analysis. JAMA Ophthalmol. 2021 Apr 01; 139(4):389-397. PMID: 33538789.
      Citations:    
    8. Stevens W, Brown GC, Brown MM, Stein JD, Sharma S. Vision-related quality-of-life estimates in adolescent youths. Can J Ophthalmol. 2021 12; 56(6):385-390. PMID: 33592178.
      Citations:    
    9. Brown GC, Brown MM, Rapuano SB, Boyer D. A Cost-Benefit Analysis of VEGF-Inhibitor Therapy for Neovascular Age-Related Macular Degeneration in the United States. Am J Ophthalmol. 2021 03; 223:405-429. PMID: 32681907.
      Citations:    
    10. Brown GC, Brown MM, Rapuano S, Boyer D. Cost-Utility Analysis of VEGF Inhibitors for Treating Neovascular Age-Related Macular Degeneration. Am J Ophthalmol. 2020 10; 218:225-241. PMID: 32565050.
      Citations:    
    11. Rostami B, Nguyen-Cuu J, Brown G, Brown M, Sadun AA, Sebag J. Reply to Comment on: Cost-Effectiveness of Limited Vitrectomy for Vision Degrading Myodesopsia. Am J Ophthalmol. 2020 05; 213:323-324. PMID: 32139079.
      Citations:    
    12. Brown MM, Brown GC. Economic Evaluation of Anti-Vascular Endothelial Growth Factor Therapy for Wet Age-Related Macular Degeneration. JAMA Ophthalmol. 2020 01 01; 138(1):48-49. PMID: 31725831.
      Citations:    
    13. Brown GC, Brown MM. Re: Hughes et?al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424). Ophthalmology. 2019 10; 126(10):e76. PMID: 31543114.
      Citations:    
    14. Brown GC, Brown MM, Busbee BG. Cost-utility analysis of cataract surgery in the United States for the year 2018. J Cataract Refract Surg. 2019 07; 45(7):927-938. PMID: 31262482.
      Citations:    
    15. Brown GC, Brown MM, Sharma S. Ethnicity and Diabetic Quality-of-Life. Am J Med Sci. 2019 08; 358(2):121-126. PMID: 31331449.
      Citations:    
    16. Brown GC, Brown MM. Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma. J Ocul Pharmacol Ther. 2019 04; 35(3):145-160. PMID: 30920338.
      Citations:    
    17. Rostami B, Nguyen-Cuu J, Brown G, Brown M, Sadun AA, Sebag J. Cost-Effectiveness of Limited Vitrectomy for Vision-Degrading Myodesopsia. Am J Ophthalmol. 2019 08; 204:1-6. PMID: 30849342.
      Citations:    
    18. De Salvo G, Brown GC, Brown MM. Vision utilities in Italy and the United States: Comparison of time tradeoff vision utilities. Eur J Ophthalmol. 2020 Mar; 30(2):253-257. PMID: 30696257.
      Citations:    
    19. Brown GC, Brown MM, Stein JD, Smiddy WE. Vision-Related Quality of Life Associated with Unilateral and Bilateral Ocular Conditions. Ophthalmology. 2018 07; 125(7):965-971. PMID: 29477690.
      Citations:    
    20. Yannuzzi NA, Chang JS, Brown GC, Smiddy WE. Cost-Utility of Evaluation for Posterior Vitreous Detachment and Prophylaxis of Retinal Detachment. Ophthalmology. 2018 01; 125(1):43-50. PMID: 28732590.
      Citations:    
    21. Brown G, Yoo J, Brown M, Turpcu A, Rajput Y. The Burden of Retinal Venous Occlusion: An Assessment of Fellow Eyes in 1000 Cases. Ophthalmol Retina. 2017 Sep - Oct; 1(5):404-412. PMID: 31047570.
      Citations:    
    22. Brown GC, Brown MM, Lieske HB, Turpcu A, Rajput Y. The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited. Int J Retina Vitreous. 2017; 3:5. PMID: 28289548.
      Citations:    
    23. Rahimy E, Doyle BC, Brown GC. RUPTURED RETINAL ARTERIAL MACROANEURYSM ON THE OPTIC DISK. Retin Cases Brief Rep. 2017 Winter; 11(1):12-14. PMID: 26829446.
      Citations:    
    24. da Cruz L, Dorn JD, Humayun MS, Dagnelie G, Handa J, Barale PO, Sahel JA, Stanga PE, Hafezi F, Safran AB, Salzmann J, Santos A, Birch D, Spencer R, Cideciyan AV, de Juan E, Duncan JL, Eliott D, Fawzi A, Olmos de Koo LC, Ho AC, Brown G, Haller J, Regillo C, Del Priore LV, Arditi A, Greenberg RJ. Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial. Ophthalmology. 2016 10; 123(10):2248-54. PMID: 27453256.
      Citations:    
    25. Brown MM, Brown GC, Lieske HB, Tran I, Turpcu A, Colman S. SOCIETAL COSTS ASSOCIATED WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN THE UNITED STATES. Retina. 2016 Feb; 36(2):285-98. PMID: 26428606.
      Citations:    
    26. Olk RJ, Peralta E, Gierhart DL, Brown GC, Brown MM. Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis. Int J Retina Vitreous. 2015; 1:22. PMID: 27847615.
      Citations:    
    27. Brown GC, Brown MM, Menezes A, Busbee BG, Lieske HB, Lieske PA. Reply: To PMID 24246824. Ophthalmology. 2015 Nov; 122(11):e70-1. PMID: 26798857.
      Citations:    
    28. Brown GC, Brown MM. Value-Based Medicine and Pharmacoeconomics. Dev Ophthalmol. 2016; 55:381-90. PMID: 26501688.
      Citations:    
    29. Brown GC, Brown MM, Lieske HB, Lieske PA, Brown KS. A Value-Based Medicine cost-utility analysis of genetic testing for neovascular macular degeneration. Int J Retina Vitreous. 2015; 1:19. PMID: 27847612.
      Citations:    
    30. Brown GC, Brown MM, Fischer DH. Photopsias: A Key to Diagnosis. Ophthalmology. 2015 Oct; 122(10):2084-94. PMID: 26249730.
      Citations:    
    31. Ho AC, Humayun MS, Dorn JD, da Cruz L, Dagnelie G, Handa J, Barale PO, Sahel JA, Stanga PE, Hafezi F, Safran AB, Salzmann J, Santos A, Birch D, Spencer R, Cideciyan AV, de Juan E, Duncan JL, Eliott D, Fawzi A, Olmos de Koo LC, Brown GC, Haller JA, Regillo CD, Del Priore LV, Arditi A, Geruschat DR, Greenberg RJ. Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind. Ophthalmology. 2015 Aug; 122(8):1547-54. PMID: 26162233.
      Citations:    
    32. Chaudry I, Brown GC, Brown MM. Medical student and patient perceptions of quality of life associated with vision loss. Can J Ophthalmol. 2015 Jun; 50(3):217-24. PMID: 26040222.
      Citations:    
    33. Brown GC, Brown MM, Turpcu A, Rajput Y. The Cost-Effectiveness of Ranibizumab for the Treatment of Diabetic Macular Edema. Ophthalmology. 2015 Jul; 122(7):1416-25. PMID: 25935787.
      Citations:    
    34. Rahimy E, Fineman MS, Regillo CD, Spirn MJ, Hsu J, Kaiser RS, Maguire JI, Brown GC, Chiang A. Speculum versus Bimanual Lid Retraction during Intravitreal Injection. Ophthalmology. 2015 Aug; 122(8):1729-30. PMID: 25726752.
      Citations:    
    35. Brown GC, Basha MM, Brown MM. Neovascular age-related macular degeneration associated with no light perception. Ophthalmic Surg Lasers Imaging Retina. 2015 Feb; 46(2):229-34. PMID: 25707049.
      Citations:    
    36. Basha M, Brown GC, Palombaro G, Shields CL, Shields JA. Management of IRVAN syndrome with observation. Ophthalmic Surg Lasers Imaging Retina. 2014 May 01; 45 Online:e18-22. PMID: 24766157.
      Citations:    
    37. Brown MM, Brown GC, Lieske HB, Lieske PA. Financial return-on-investment of ophthalmic interventions: a new paradigm. Curr Opin Ophthalmol. 2014 May; 25(3):171-6. PMID: 24638114.
      Citations:    
    38. Brown GC, Busbee BG. Our advances are fabulous. Then what is the problem? Curr Opin Ophthalmol. 2014 May; 25(3):155-7. PMID: 24675285.
      Citations:    
    39. Brown GC, Brown MM, Menezes A, Busbee BG, Lieske HB, Lieske PA. Cataract surgery cost utility revisited in 2012: a new economic paradigm. Ophthalmology. 2013 Dec; 120(12):2367-2376. PMID: 24246824.
      Citations:    
    40. Brown GC. We are producers of patient value and financial value. Curr Opin Ophthalmol. 2013 May; 24(3):181-2. PMID: 23549600.
      Citations:    
    41. Brown MM, Brown GC. Update on value-based medicine. Curr Opin Ophthalmol. 2013 May; 24(3):183-9. PMID: 23492432.
      Citations:    
    42. Baker PS, Garg SJ, Fineman MS, Chiang A, Alshareef RA, Belmont J, Brown GC. Serous macular detachment in Waldenstr?m macroglobulinemia: a report of four cases. Am J Ophthalmol. 2013 Mar; 155(3):448-55. PMID: 23218691.
      Citations:    
    43. Kim SJ, Scott IU, Brown GC, Brown MM, Ho AC, Ip MS, Recchia FM. Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology. Ophthalmology. 2013 Feb; 120(2):371-8. PMID: 23062648.
      Citations:    
    44. Ho AC, Scott IU, Kim SJ, Brown GC, Brown MM, Ip MS, Recchia FM. Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology. Ophthalmology. 2012 Oct; 119(10):2179-88. PMID: 22917890.
      Citations:    
    45. Brown MM, Brown GC, Lieske HB, Lieske PA. Preference-based comparative effectiveness and cost?effectiveness: a review and relevance of value-based medicine for vitreoretinal interventions. Curr Opin Ophthalmol. 2012 May; 23(3):163-74. PMID: 22487884.
      Citations:    
    46. Brown GC. Advances in quality-of-life and the financial independence of patients. Curr Opin Ophthalmol. 2012 May; 23(3):161-2. PMID: 22487883.
      Citations:    
    47. Orlin A, Hadley D, Chang W, Ho AC, Brown G, Kaiser RS, Regillo CD, Godshalk AN, Lier A, Kaderli B, Stambolian D. Association between high-risk disease loci and response to anti-vascular endothelial growth factor treatment for wet age-related macular degeneration. Retina. 2012 Jan; 32(1):4-9. PMID: 21878851.
      Citations:    
    48. Kaiser RS, Gupta OP, Regillo CD, Ho AC, Fineman MS, Vander JF, McNamara JA, Brown GC. Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical response. Ophthalmic Surg Lasers Imaging. 2012 Jan-Feb; 43(1):13-9. PMID: 21986085.
      Citations:    
    49. Brown GC, Brown MM, Lieske HB, Lieske PA, Brown KS, Lane SS. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope. Ophthalmology. 2011 Sep; 118(9):1834-43. PMID: 21723614.
      Citations:    
    50. Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology. 2011 Oct; 118(10):2028-34. PMID: 21705087.
      Citations:    
    51. London NJ, Brown G. Update and review of central retinal vein occlusion. Curr Opin Ophthalmol. 2011 May; 22(3):159-65. PMID: 21460724.
      Citations:    
    52. Witkin AJ, Brown GC. Update on nonsurgical therapy for diabetic macular edema. Curr Opin Ophthalmol. 2011 May; 22(3):185-9. PMID: 21427573.
      Citations:    
    53. Brown MM, Brown GC, Leiske HB, Lieske PA. Healthcare costs, buyer alert. Curr Opin Ophthalmol. 2011 May; 22(3):149-51. PMID: 21460725.
      Citations:    
    54. Brown GC. Changes in the practice of vitreoretinal disease. Editorial. Curr Opin Ophthalmol. 2011 May; 22(3):147-8. PMID: 21483263.
      Citations:    
    55. Recchia FM, Scott IU, Brown GC, Brown MM, Ho AC, Ip MS. Small-gauge pars plana vitrectomy: a report by the American Academy of Ophthalmology. Ophthalmology. 2010 Sep; 117(9):1851-7. PMID: 20816248.
      Citations:    
    56. Brown MM, Brown GC. Cost-utility analysis, the pearl in the crown. Can J Ophthalmol. 2010 Jun; 45(3):211-4. PMID: 20628418.
      Citations:    
    57. Brown G, Brown MM. Let us wake the nation on the treatment for age-related macular degeneration. Curr Opin Ophthalmol. 2010 May; 21(3):169-71. PMID: 20397317.
      Citations:    
    58. Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, Tosakulwong N, Pericak-Vance MA, Campochiaro PA, Klein ML, Tan PL, Conley YP, Kanda A, Kopplin L, Li Y, Augustaitis KJ, Karoukis AJ, Scott WK, Agarwal A, Kovach JL, Schwartz SG, Postel EA, Brooks M, Baratz KH, Brown WL, Brucker AJ, Orlin A, Brown G, Ho A, Regillo C, Donoso L, Tian L, Kaderli B, Hadley D, Hagstrom SA, Peachey NS, Klein R, Klein BE, Gotoh N, Yamashiro K, Ferris Iii F, Fagerness JA, Reynolds R, Farrer LA, Kim IK, Miller JW, Cort?n M, Carracedo A, Sanchez-Salorio M, Pugh EW, Doheny KF, Brion M, Deangelis MM, Weeks DE, Zack DJ, Chew EY, Heckenlively JR, Yoshimura N, Iyengar SK, Francis PJ, Katsanis N, Seddon JM, Haines JL, Gorin MB, Abecasis GR, Swaroop A. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A. 2010 Apr 20; 107(16):7401-6. PMID: 20385819.
      Citations:    
    59. Goodwin P, Shields CL, Ramasubramanian A, Brown GC, Shields JA. Ranibizumab for coloboma-related choroidal neovascular membrane in a child. J AAPOS. 2009 Dec; 13(6):616-7. PMID: 20006832.
      Citations:    
    60. Hadley D, Orlin A, Brown G, Brucker AJ, Ho AC, Regillo CD, Donoso LA, Tian L, Kaderli B, Stambolian D. Analysis of six genetic risk factors highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26. Invest Ophthalmol Vis Sci. 2010 Apr; 51(4):2191-6. PMID: 19933195.
      Citations:    
    61. Shields JA, Eagle RC, Shields CL, Brown GC, Lally SE. Malignant transformation of congenital hypertrophy of the retinal pigment epithelium. Ophthalmology. 2009 Nov; 116(11):2213-6. PMID: 19744732.
      Citations:    
    62. Choudhry N, Ramasubramanian A, Shields CL, Brown G, Shields JA. Spontaneous resolution of retinal detachment in morning glory disk anomaly. J AAPOS. 2009 Oct; 13(5):499-500. PMID: 19717323.
      Citations:    
    63. Brown MM, Luo B, Brown HC, Brown GC. Comparative effectiveness: its role in the healthcare system. Curr Opin Ophthalmol. 2009 May; 20(3):188-94. PMID: 19425205.
      Citations:    
    64. Brown GC, Brown MM. Comparative effectiveness. Curr Opin Ophthalmol. 2009 May; 20(3):147-50. PMID: 19387344.
      Citations:    
    65. Baker PS, Brown GC. Stem-cell therapy in retinal disease. Curr Opin Ophthalmol. 2009 May; 20(3):175-81. PMID: 19425203.
      Citations:    
    66. Chen E, Ho AC, Garg SJ, Brown GC, Kaiser RS. Streptococcus mitis endophthalmitis presenting as frosted branch angiitis after intravitreal pegaptanib sodium injection. Ophthalmic Surg Lasers Imaging. 2009 Mar-Apr; 40(2):192-4. PMID: 19320312.
      Citations:    
    67. Brown MM, Brown GC, Brown HC, Peet J, Roth Z. Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome. Arch Ophthalmol. 2009 Feb; 127(2):146-52. PMID: 19204231.
      Citations:    
    68. Roe RH, Lass JH, Brown GC, Brown MM. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus. Cornea. 2008 Oct; 27(9):1001-7. PMID: 18812762.
      Citations:    
    69. Ip MS, Scott IU, Brown GC, Brown MM, Ho AC, Huang SS, Recchia FM. Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology. Ophthalmology. 2008 Oct; 115(10):1837-46. PMID: 18929163.
      Citations:    
    70. Brown GC, Brown MM. Cost-effectiveness. Ophthalmology. 2008 Aug; 115(8):1433; author reply 1433-4. PMID: 18675701.
      Citations:    
    71. Shah CP, Ho AC, Regillo CD, Fineman MS, Vander JF, Brown GC. Short-term outcomes of 25-gauge vitrectomy with silicone oil for repair of complicated retinal detachment. Retina. 2008 May; 28(5):723-8. PMID: 18463516.
      Citations:    
    72. Brown MM, Brown GC, Brown HC, Irwin B, Brown KS. The comparative effectiveness and cost-effectiveness of vitreoretinal interventions. Curr Opin Ophthalmol. 2008 May; 19(3):202-7. PMID: 18408494.
      Citations:    
    73. Brown G. Comparative effectiveness. Curr Opin Ophthalmol. 2008 May; 19(3):175-6. PMID: 18408489.
      Citations:    
    74. Gupta OP, Brown GC, Brown MM. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery. Am J Ophthalmol. 2008 May; 145(5):923-8. PMID: 18329000.
      Citations:    
    75. Luo BP, Brown GC, Luo SC, Brown MM. The quality of life associated with presbyopia. Am J Ophthalmol. 2008 Apr; 145(4):618-622. PMID: 18243152.
      Citations:    
    76. Brown MM, Brown GC, Brown HC, Peet J. A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration. Ophthalmology. 2008 Jun; 115(6):1039-1045.e5. PMID: 17976724.
      Citations:    
    77. Gupta OP, Brown GC, Brown MM. Age-related macular degeneration: the costs to society and the patient. Curr Opin Ophthalmol. 2007 May; 18(3):201-5. PMID: 17435426.
      Citations:    
    78. Brown MM, Brown GC, Brown H. Value-based medicine and interventions for macular degeneration. Curr Opin Ophthalmol. 2007 May; 18(3):194-200. PMID: 17435425.
      Citations:    
    79. Brown GC, Brown MM, Brown H, Godshalk AN. Pharmacoeconomics and macular degeneration. Curr Opin Ophthalmol. 2007 May; 18(3):206-11. PMID: 17435427.
      Citations:    
    80. Brown GC, Brown MM, Brown HC, Kindermann S, Sharma S. A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration. Ophthalmology. 2007 Jun; 114(6):1170-8. PMID: 17320964.
      Citations:    
    81. Brown GC, Brown MM, Brown HC, Kindermann S, Sharma S. The goal of value-based medicine analyses: comparability. The case for neovascular macular degeneration. Trans Am Ophthalmol Soc. 2007; 105:160-9; discussion 169-71. PMID: 18427606.
      Citations:    
    82. Weichel ED, Martidis A, Fineman MS, McNamara JA, Park CH, Vander JF, Ho AC, Brown GC. Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for primary repair of pseudophakic retinal detachment. Ophthalmology. 2006 Nov; 113(11):2033-40. PMID: 17074564.
      Citations:    
    83. Chhabra S, Kunimoto DY, Kazi L, Regillo CD, Ho AC, Belmont J, Maguire J, Vander J, Brown GC. Endophthalmitis after open globe injury: microbiologic spectrum and susceptibilities of isolates. Am J Ophthalmol. 2006 Nov; 142(5):852-4. PMID: 17056367.
      Citations:    
    84. Beauchamp CL, Beauchamp GR, Stager DR, Brown MM, Brown GC, Felius J. The cost utility of strabismus surgery in adults. J AAPOS. 2006 Oct; 10(5):394-9. PMID: 17070471.
      Citations:    
    85. Hurley BR, McNamara JA, Fineman MS, Ho AC, Tasman W, Kaiser RS, Vander JF, Regillo CD, Brown GC. Laser treatment for retinopathy of prematurity: evolution in treatment technique over 15 years. Retina. 2006 Sep; 26(7 Suppl):S16-7. PMID: 16946671.
      Citations:    
    86. Brown GC. 56,000 Ways? No way! Curr Opin Ophthalmol. 2006 Jun; 17(3):219-22. PMID: 16794432.
      Citations:    
    87. Brown MM, Brown GC, Sharma S, Stein JD, Roth Z, Campanella J, Beauchamp GR. The burden of age-related macular degeneration: a value-based analysis. Curr Opin Ophthalmol. 2006 Jun; 17(3):257-66. PMID: 16794438.
      Citations:    
    88. Brown MM, Brown GC, Brown H, Sharma S, Wagner T, Kraushar M. Pain and suffering disability index. Curr Opin Ophthalmol. 2006 Jun; 17(3):292-7. PMID: 16794444.
      Citations:    
    89. Anderson NG, Fineman MS, Brown GC. Incidence of intraocular pressure spike and other adverse events after vitreoretinal surgery. Ophthalmology. 2006 Jan; 113(1):42-7. PMID: 16360213.
      Citations:    
    90. Brown GC, Brown MM, Campanella J, Beauchamp GR. The cost-utility of photodynamic therapy in eyes with neovascular macular degeneration--a value-based reappraisal with 5-year data. Am J Ophthalmol. 2005 Oct; 140(4):679-87. PMID: 16226519.
      Citations:    
    91. Brown MM, Brown GC. How to interpret a healthcare economic analysis. Curr Opin Ophthalmol. 2005 Jun; 16(3):191-4. PMID: 15870578.
      Citations:    
    92. Brown GC. Value-based medicine: the new paradigm. Curr Opin Ophthalmol. 2005 Jun; 16(3):139-40. PMID: 15870569.
      Citations:    
    93. Brown MM, Brown GC, Stein JD, Roth Z, Campanella J, Beauchamp GR. Age-related macular degeneration: economic burden and value-based medicine analysis. Can J Ophthalmol. 2005 Jun; 40(3):277-87. PMID: 15947797.
      Citations:    
    94. Ko GJ, Brown MM, Brown GC. The macroeconomics of vitreoretinal diseases. Curr Opin Ophthalmol. 2005 Jun; 16(3):184-90. PMID: 15870577.
      Citations:    
    95. Smithen LM, Brown GC, Brucker AJ, Yannuzzi LA, Klais CM, Spaide RF. Coats' disease diagnosed in adulthood. Ophthalmology. 2005 Jun; 112(6):1072-8. PMID: 15882905.
      Citations:    
    96. Vander JF, McNamara JA, Tasman W, Brown GC. Revised indications for early treatment of retinopathy of prematurity. Arch Ophthalmol. 2005 Mar; 123(3):406-7; discussion 409-10. PMID: 15767491.
      Citations:    
    97. Brown GC, Brown MM, Sharma S, Stein JD, Roth Z, Campanella J, Beauchamp GR. The burden of age-related macular degeneration: a value-based medicine analysis. Trans Am Ophthalmol Soc. 2005; 103:173-84; discussion 184-6. PMID: 17057801.
      Citations:    
    98. Brown MM, Brown GC, Sharma S. Value-based medicine and vitreoretinal diseases. Curr Opin Ophthalmol. 2004 Jun; 15(3):167-72. PMID: 15118501.
      Citations:    
    99. Luo BP, Brown GC. Update on the ocular manifestations of systemic arterial hypertension. Curr Opin Ophthalmol. 2004 Jun; 15(3):203-10. PMID: 15118507.
      Citations:    
    100. Smithen LM, Brown GC, Brown MM. Dollars and sight: the economics of ophthalmology. Curr Opin Ophthalmol. 2004 Jun; 15(3):173-80. PMID: 15118502.
      Citations:    
    101. Brown GC. One eye versus two: a value-based approach. Curr Opin Ophthalmol. 2004 Jun; 15(3):165-6. PMID: 15118500.
      Citations:    
    102. Brown MM, Brown GC. Utility assessment and dry eye disease. Ophthalmology. 2004 Apr; 111(4):852-3; author reply 853. PMID: 15051232.
      Citations:    
    103. Brown GC, Brown MM, Sharma S. Health care economic analyses. Retina. 2004 Feb; 24(1):139-46. PMID: 15076955.
      Citations:    
    104. Brown GC, Brown MM, Sharma S, Brown H, Smithen L, Leeser DB, Beauchamp G. Value-based medicine and ophthalmology: an appraisal of cost-utility analyses. Trans Am Ophthalmol Soc. 2004; 102:177-85; discussion 185-8. PMID: 15747756.
      Citations:    
    105. Busbee BG, Brown GC, Brown MM. Value-based medicine: a new paradigm to evaluate treatments for vitreoretinal diseases and other medical interventions. Int Ophthalmol Clin. 2004; 44(4):155-72. PMID: 15577570.
      Citations:    
    106. Busbee BG, Brown MM, Brown GC, Sharma S. Cost-utility analysis of cataract surgery in the second eye. Ophthalmology. 2003 Dec; 110(12):2310-7. PMID: 14644712.
      Citations:    
    107. Brown GC, Brown MM, Sharma S. Value-based medicine: evidence-based medicine and beyond. Ocul Immunol Inflamm. 2003 Sep; 11(3):157-70. PMID: 14566642.
      Citations:    
    108. Rumelt S, Brown GC. Update on treatment of retinal arterial occlusions. Curr Opin Ophthalmol. 2003 Jun; 14(3):139-41. PMID: 12777932.
      Citations:    
    109. Busbee BG, Brown MM, Brown GC, Sharma S. CME review: A cost-utility analysis of laser photocoagulation for extrafoveal choroidal neovascularization. Retina. 2003 Jun; 23(3):279-87; ; quiz 443-4. PMID: 12824826.
      Citations:    
    110. Landy J, Brown GC. Update on photodynamic therapy. Curr Opin Ophthalmol. 2003 Jun; 14(3):163-8. PMID: 12777937.
      Citations:    
    111. Brown MM, Brown GC, Sharma S, Busbee B. Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology. 2003 Jun; 110(6):1076-81. PMID: 12799229.
      Citations:    
    112. Busbee BG, Brown GC, Brown MM. Cost-effectiveness of ocular interventions. Curr Opin Ophthalmol. 2003 Jun; 14(3):132-8. PMID: 12777931.
      Citations:    
    113. Brown MM, Brown GC, Sharma S, Landy J. Health care economic analyses and value-based medicine. Surv Ophthalmol. 2003 Mar-Apr; 48(2):204-23. PMID: 12686305.
      Citations:    
    114. Shields JA, Shields CL, Brown GC, Eagle RC. Mushroom-shaped choroidal metastasis simulating a choroidal melanoma. Retina. 2002 Dec; 22(6):810-3. PMID: 12476115.
      Citations:    
    115. Membreno JH, Brown MM, Brown GC, Sharma S, Beauchamp GR. A cost-utility analysis of therapy for amblyopia. Ophthalmology. 2002 Dec; 109(12):2265-71. PMID: 12466169.
      Citations:    
    116. Landy J, Stein J, Brown MM, Brown GC, Sharma S. Patient, community and clinician perceptions of the quality of life associated with diabetes mellitus. Med Sci Monit. 2002 Aug; 8(8):CR543-8. PMID: 12165739.
      Citations:    
    117. Brown MM, Brown GC, Sharma S, Landy J, Bakal J. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol. 2002 Apr; 120(4):481-4. PMID: 11934322.
      Citations:    
    118. Brown GC, Brown MM, Sharma S, Busbee B, Landy J. A cost-utility analysis of interventions for severe proliferative vitreoretinopathy. Am J Ophthalmol. 2002 Mar; 133(3):365-72. PMID: 11860974.
      Citations:    
    119. Busbee BG, Brown MM, Brown GC, Sharma S. Incremental cost-effectiveness of initial cataract surgery. Ophthalmology. 2002 Mar; 109(3):606-12; discussion 612-3. PMID: 11874769.
      Citations:    
    120. Brown GC, Brown MM, Sharma S, Busbee B, Brown H. Incremental cost-effectiveness of laser therapy for visual loss secondary to branch retinal vein occlusion. Ophthalmic Epidemiol. 2002 Feb; 9(1):1-10. PMID: 11815891.
      Citations:    
    121. Brown MM, Brown GC, Sharma S, Hollands H, Landy J. Quality of life and systemic comorbidities in patients with ophthalmic disease. Br J Ophthalmol. 2002 Jan; 86(1):8-11. PMID: 11801494.
      Citations:    
    122. Brown MM, Brown GC. Outcome of corneal transplantation. Br J Ophthalmol. 2002 Jan; 86(1):2-3. PMID: 11801491.
      Citations:    
    Brown's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (317)
    Explore
    _
    Co-Authors (16)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _